Reprocessed Medical Devices Market Growth & Trends
The global reprocessed medical devices market size is estimated to reach USD 5.08 billion by 2030, registering to grow at a CAGR of 16.95% from 2025 to 2030 according to a new report by Grand View Research, Inc. The increasing need for affordable & effective medical devices and growing concern regarding the rising amounts of medical waste generated by healthcare facilities are expected to drive the market. In addition, the long-term cost-efficiency associated with these devices as compared to that of the original device is expected to further drive the market growth. Medical device reprocessing has become an increasingly popular way of saving costs among healthcare organizations. According to the Association of Medical Device Reprocessors (AMDR), these reprocessed devices are typically 30-50% cheaper than new ones. Hospitals and other healthcare facilities take advantage of this cost-effective resource to enhance services and advance their technology.
It also allows them to allocate funds to important areas like hiring additional personnel or updating equipment, while still ensuring quality of care. Moreover, data published by the AMDR reveals that hospitals are responsible for 8.5% of the Greenhouse Gas (GHG) emissions in the U.S. and 5% of global outputs. Studies suggest these emissions reduce life expectancy in the U.S. by 388,000 disability-adjusted years. Over 80% of emissions come from the healthcare supply chain. A 2021 study conducted by the Fraunhofer Institute for Environmental, Safety, and Energy Technology concluded that using reprocessed medical equipment could drastically reduce the global warming impact of such devices by 40%, reduce ozone depletion by 90%, and diminish the utilization of the finite abiotic resources by 29%. The COVID-19 pandemic had a significant impact on the market. However, an increasing amount of medical waste around the world has become a major concern.
Reprocessing can help address this challenge by reducing waste and prolonging the life of products. Medical device reprocessors have begun introducing sustainable solutions to improve waste management and prevent health risks to the public, patients, healthcare staff, and waste workers. All such factors are expected to drive the industry growth during the forecast period. Several medical device companies, including subsidiaries of prominent organizations, such as Arjo, Cardinal, Medline, and Stryker, engage in remanufacturing Single-Use Devices (SUDs) as part of their sustainability initiatives. For instance, in January 2023, Vanguard AG announced its strategic partnership with Leeds Teaching Hospitals NHS Trust, one of the UK’s largest and most prominent healthcare providers. This collaboration aims to promote the use of remanufactured medical devices to reduce costs and foster a more sustainable healthcare environment.
Reprocessed Medical Devices Market Report Highlights
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook